Actively Recruiting
Spermatogonial Differentiation Via Testicular Organoid
Led by CellARTs Inc. · Updated on 2025-02-24
100
Participants Needed
1
Research Sites
144 weeks
Total Duration
On this page
Sponsors
C
CellARTs Inc.
Lead Sponsor
T
The Turek Clinic, Inc
Collaborating Sponsor
AI-Summary
What this Trial Is About
Purpose: This clinical trial aims to explore the potential for human sperm production in vitro by sustaining a laboratory-cultured adult testicular environment. It also seeks to identify genetic factors contributing to human sterility and failed spermatogenesis. The study's primary objectives include: 1. Identifying genomic markers associated with sterility and failed spermatogenesis. 2. Developing an ex vivo (outside the body) testis "organ-on-a-chip" ("iTestis") to support stem cell cultivation. 3. Determining whether human spermatogenesis can be re-created in vitro using stem cells nurtured in the iTestis model. Study Description: Researchers will analyze the genomic profiles of fertile and sterile male participants to map genetic abnormalities associated with sterility. Using testicular and skin tissue samples from participants, spermatogonial stem cells and pluripotent stem cells will be isolated and utilized to construct the ex vivo iTestis. This system will integrate genomic insights and prior research to foster human spermatogenesis outside the body. Participant Involvement: Participants will provide the following samples: * Blood sample for serum analysis. * A skin tissue biopsy. * Testicular tissue, obtained through fine needle aspiration (FNA) or testicular sperm extraction (TESE), as part of a routine procedure. All procedures will be conducted by the principal investigator and qualified research staff, ensuring participant safety and adherence to ethical guidelines.
CONDITIONS
Official Title
Spermatogonial Differentiation Via Testicular Organoid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male sex between 18 and 60 years old
- Evidence of fertility or normal spermatogenesis for fertile control group
- Undergoing planned fertility or infertility procedures for clinical purposes
- For infertile groups: infertility lasting more than 1 year
- Diagnosis of azoospermia based on clinical evaluation for infertile groups
You will not qualify if you...
- Lack of diagnosis of fertility or infertility
- Absence of testicles
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Turek Clinic
San Francisco, California, United States, 94108
Actively Recruiting
Research Team
E
Erica S Godart, BS
CONTACT
C
Constance John, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here